Incorporated in 2001, China Health Resources Co., Ltd. (CHRI) has grown to become one of the leading industrialized agricultural corporations in China. The company is engaged in the production and processing of Chinese traditional medicines, such as the widely used Dahurian Angelica Root.
Today the company announced it has secured a project investment contract with Guangzhou Qingping Market to build Herb Network Logistics and a Sales Platform. According to the press release, the companies’ aggregate $3 million investment into the project will expand the herb market of spot trade and futures trade through e-commerce.
In the statement, China Health said it’s technological and natural resources, paired with Qinping’s market advantages, will enhance the competency of the platform. China Health’s current business plan is to distribute DAR products for the treatment of pain, swelling and pustule. China Health attained the Good Agricultural Practice certification, a national compulsory criterion for food and drug industries, for its DAR products and related production technology. This will assist the company in battling harmful micro-organisms to ensure agricultural safety.
The logistics and sales platform project will commence this month, and is expected to be completed in 2009.
Let us hear your thoughts: China Health Resource, Inc. Message Board